NCT03085069 2023-02-16A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCJiangsu HengRui Medicine Co., Ltd.Phase 2 Unknown146 enrolled
NCT04133337 2019-10-21Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLCSichuan Cancer Hospital and Research InstitutePhase 1/2 Unknown20 enrolled